US President Donald Trump launched a new government website, TrumpRx.gov, aimed at reducing prescription drug costs for Americans, according to Euronews. The website, announced Thursday, features over 40 medications from five pharmaceutical companies that reached pricing agreements with the administration. Meanwhile, the European Commission warned TikTok that its "addictive design" may breach Europe's new content rules, as reported by Ars Technica.
The Trump administration framed the initiative as a challenge to the pharmaceutical industry's pricing power, Euronews reported. The website promises "the world's lowest prices," according to the same source. The pharmaceutical companies involved in the pricing agreements are AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer. Trump stated, "You're going to save a fortune," and added, "This is also so good for overall healthcare."
In other news, the Norwegian government accused the Chinese-backed hacking group known as Salt Typhoon of breaking into several organizations in the country, as reported by TechCrunch. The Norwegian Police Security Service stated the hacking group, believed to be working for the Chinese government, targeted vulnerable network devices to conduct espionage. Salt Typhoon has been described as an "epoch-defining threat" by senior U.S. national security officials, and has allegedly intercepted communications of senior politicians.
The European Commission's warning to TikTok, also reported by Ars Technica, stems from preliminary findings issued on Friday. The commission believes TikTok has failed to adequately assess and mitigate the risks posed by addictive design features that could harm users, particularly children and other vulnerable groups. This warning marks one of the most advanced tests yet of the EU's Digital Services Act.
In the tech sector, AI is being explored to solve complex problems. According to TechCrunch, AI is becoming a "force multiplier" in treating rare diseases, with executives from Insilico Medicine and GenEditBio highlighting the need for more skilled professionals in the field. Insilico's CEO and founder, Alex Aliper, aims to develop pharmaceutical superintelligence.
Also, Anthropic and OpenAI released products built around the idea of managing teams of AI agents, shifting from AI as a conversation partner to AI as a delegated workforce, according to Ars Technica. This shift reportedly helped wipe $285 billion off software stocks. However, whether this supervisory model works in practice remains an open question, as current AI agents still require heavy human intervention to catch errors.
Discussion
AI Experts & Community
Be the first to comment